Syncom Formulation (India) (NSE:SYNCOMF) EV-to-Revenue : 5.02 (As of May. 11, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Syncom Formulation (India)'s enterprise value is ₹12,454 Mil. Syncom Formulation (India)'s Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹2,480 Mil. Therefore, Syncom Formulation (India)'s EV-to-Revenue for today is 5.02.

The historical rank and industry rank for Syncom Formulation (India)'s EV-to-Revenue or its related term are showing as below:

NSE:SYNCOMF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.22 Med: 1.61 Max: 6.63
Current: 5.02

During the past 13 years, the highest EV-to-Revenue of Syncom Formulation (India) was 6.63. The lowest was 0.22. And the median was 1.61.

NSE:SYNCOMF's EV-to-Revenue is ranked worse than
75.56% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs NSE:SYNCOMF: 5.02

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), Syncom Formulation (India)'s stock price is ₹13.05. Syncom Formulation (India)'s Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹2.74. Therefore, Syncom Formulation (India)'s PS Ratio for today is 4.76.

Syncom Formulation (India) EV-to-Revenue Historical Data

The historical data trend for Syncom Formulation (India)'s EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) EV-to-Revenue Chart

Syncom Formulation (India) Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Get a 7-Day Free Trial

0.47

0.25

0.97

4.29

2.55

Syncom Formulation (India) Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															3.80	2.55	3.09	3.36	5.70

Competitive Comparison of Syncom Formulation (India)'s EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syncom Formulation (India)'s EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s EV-to-Revenue falls into.

Syncom Formulation (India) EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Syncom Formulation (India)'s EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	12454.009	/	2480.256
	=	5.02

Syncom Formulation (India)'s current Enterprise Value is ₹12,454 Mil.
Syncom Formulation (India)'s Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,480 Mil.

Syncom Formulation (India) (NSE:SYNCOMF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Syncom Formulation (India)'s PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	13.05	/	2.74
	=	4.76

Syncom Formulation (India)'s share price for today is ₹13.05.
Syncom Formulation (India)'s Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.74.

Syncom Formulation (India) EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Syncom Formulation (India) (NSE:SYNCOMF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » EV-to-Revenue

Traded in Other Exchanges

524470:India

Address

207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018

Website

https://www.sfil.in

Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (NSE:SYNCOMF) Headlines

No Headlines